Identification and validation of obesity related genes signature based on microenvironment phenotypes in prostate adenocarcinoma
Aging · 2023
DOI: 10.18632/aging.205065 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging, 2023. Verfasst von Linghui Liang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Affiliated Wuxi No. 2 Hospital, Nanjing Medical University and Jiangnan University Medical Center, Wuxi, Jiangsu, China. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Adenocarcinoma. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Affiliated Wuxi No. 2 Hospital, Nanjing Medical University and Jiangnan University Medical Center, Wuxi, Jiangsu, China.
- Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
- Nantong University Medical School, Nantong, Jiangsu, China.
- Nanjing Medical University, Nanjing, Jiangsu, China.
Zitieren
APA
Liang, L., Shang, J., Zhang, Y., Xu, Y., Zhouteng, Y., Wen, J., Zhao, Y., Feng, N., & Zhao, R. (2023). Identification and validation of obesity related genes signature based on microenvironment phenotypes in prostate adenocarcinoma. Aging. https://doi.org/10.18632/aging.205065
Vancouver
Liang L, Shang J, Zhang Y, Xu Y, Zhouteng Y, Wen J, et al. Identification and validation of obesity related genes signature based on microenvironment phenotypes in prostate adenocarcinoma. Aging. 2023. doi:10.18632/aging.205065
BibTeX
@article{Liang2023,
author = {Liang, Linghui and Shang, Jinwei and Zhang, Yuwei and Xu, Yuxin and Zhouteng, Yihui and Wen, Jianxiang and Zhao, Yuxin and Feng, Ninghan and Zhao, Ruizhe},
title = {Identification and validation of obesity related genes signature based on microenvironment phenotypes in prostate adenocarcinoma},
journal = {Aging},
year = {2023},
doi = {10.18632/aging.205065}
}
EUVIMED